Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.
about
Immunovirological parameters and cytokines in HIV infectionUnderstanding frailty, aging, and inflammation in HIV infectionEpstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infectionCross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapyAgeing and inflammation in patients with HIV infection.Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections.HIV persistence: chemokines and their signalling pathways.Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapyImmune Activation: Contribution to AIDS-Associated Non-Hodgkin LymphomaAssociation between systemic inflammation and obstructive sleep apnea in men with or at risk for HIV infectionImpact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study.The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation.HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscapePersistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy.Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphomaThe effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.Multisite comparison of high-sensitivity multiplex cytokine assays.Control of Viremia Enables Acquisition of Resting Memory B Cells with Age and Normalization of Activated B Cell Phenotypes in HIV-Infected ChildrenDysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients.Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapyInflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative AdultsLoss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infection.Plasma Selenium Concentrations Are Sufficient and Associated with Protease Inhibitor Use in Treated HIV-Infected AdultsIncreased levels of circulating cytokines with HIV-related immunosuppression.Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapyAssociations of Circulating Soluble Tumor Necrosis Factor-α Receptors 1 and 2 with Interleukin-6 Levels in an Aging Cohort of Injection Drug Users with or at High Risk for HIV InfectionDynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques.Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).Role of IL-21 and IL-21 receptor on B cells in HIV infection.Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma riskOne of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.Immunology of pediatric HIV infectionChronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressorsTLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosisOlder HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study.Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals.
P2860
Q26829264-75787973-1B34-40A5-BAB6-8CAB094253F0Q27021143-25BDA660-FA01-42E3-B2A9-0D570BC1848BQ27022706-4A98E333-6BF7-4229-AC27-EC869038E735Q28740329-547E2D58-9083-4BFF-BE86-40A84E1A749CQ30244296-141B18D9-3C0D-4D85-AC4A-96AD2CC82ECBQ30558355-E2A92AFC-7DF0-41C9-9193-88D6D96D6E9BQ33774665-7B2C4E35-B6FE-43AE-8EF7-62CA9CC14A44Q33865785-9215DDDF-45BA-4EA1-AB4C-792624C05237Q33887336-922C0387-1BAA-4E64-BF78-6DD30C9CA81BQ34036498-0B61C764-DECE-4371-955A-B741D2EA1B19Q34195066-873B8D08-8F36-4B3D-B61B-914E68E9F498Q34652175-E8B84A9F-6614-49A5-8908-30E168F047B5Q34671009-EBC028AE-F8AC-477D-A542-38511A9EC251Q34766189-8CA9C609-AFAE-47B6-AF60-B87EDC935C04Q35009761-3B8F5D1D-4685-4C3F-A541-CE3DDA8061B6Q35030011-64140777-65A2-4F50-90F1-4F52CC2378D0Q35138815-3E3ABB69-F0CD-43E6-B432-C67E62122C84Q35861977-CE3DB6CD-959F-41AF-9665-EA02A90E11C9Q35873402-3B2A807D-AC8A-4B99-9755-B7DC74A3B83AQ35935289-9D65CDA6-255B-4ECC-AD6F-EF84E9F4EC6BQ35940864-E2EC0C28-9953-4882-B724-66B5540AF35EQ36052919-935E47F6-43BF-430A-A6F5-53BC5E4F790CQ36087826-2B44B4F4-97AC-450E-812C-3A928771347FQ36102520-0B6B9915-67FE-4736-81EF-CE5AC1E6AC7DQ36198944-54B1300A-A2BD-4576-8014-019A749C9D8EQ36330047-7C40F264-9DBF-4657-A01C-C62BC16531F8Q36397469-3270A68F-6AC4-4D3F-9127-59C8EC289809Q36403297-A0DCA0B5-44EC-4808-9507-D09F52D494D2Q36471585-ECA92CFB-A370-4986-89EC-E869B5764C4AQ36670538-7E9330B4-62D0-477B-AEC3-E34FE2B501D4Q36988704-A79A44F2-28C8-49B6-8062-91A413E76B09Q37034835-31AC1AD8-F3AE-438A-BFF0-0DC775D0C060Q37080573-C9D010FD-E360-42DC-AF94-1B9E606BD85BQ37169522-0FC25FEA-5F2B-434E-9DA1-5846E4E2E936Q37185126-6CEAA7B1-3FB4-46EA-A438-3BE28EE4FDB5Q37247131-3B956027-A4DB-426A-BE29-E603341BA1F7Q37323664-2A06DB86-2616-4313-A556-C6040DAF6AD5Q37484124-253BCF06-EBA1-4254-A4AF-2104C3244673Q37862747-2A66829D-63D3-4E59-9021-263BE5C62C14Q38114912-5F2B7E5C-B72F-44C4-9F45-E0CE1849D02E
P2860
Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effect of highly active antire ...... e activation and inflammation.
@ast
Effect of highly active antire ...... e activation and inflammation.
@en
type
label
Effect of highly active antire ...... e activation and inflammation.
@ast
Effect of highly active antire ...... e activation and inflammation.
@en
prefLabel
Effect of highly active antire ...... e activation and inflammation.
@ast
Effect of highly active antire ...... e activation and inflammation.
@en
P2093
P2860
P1433
P1476
Effect of highly active antire ...... e activation and inflammation.
@en
P2093
Charles R Rinaldo
Daniel P Widney
Deborah L Regidor
Elizabeth C Breen
Frank Palella
Jay H Bream
Lisa P Jacobson
Roger Detels
P2860
P304
P356
10.1097/QAD.0B013E32834273AD
P407
P577
2011-01-01T00:00:00Z